222 related articles for article (PubMed ID: 31096813)
1. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.
Paige E; Haywood P; Xie M; Worth L; Thursky K; Urbancic K; Bajel A; Slavin M
Leuk Lymphoma; 2019 Oct; 60(10):2373-2383. PubMed ID: 31096813
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
Lum L; Lee A; Vu M; Strasser S; Davis R
Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
[TBL] [Abstract][Full Text] [Related]
4. Fungal infections in pediatric patients with acute myeloid leukemia in a tertiary hospital.
Ávila Montiel D; Saucedo Campos A; Avilés Robles M; Murillo Maldonado MA; Jiménez Juárez R; Silva Dirzo M; Dorantes Acosta E
Front Public Health; 2023; 11():1056489. PubMed ID: 37033052
[TBL] [Abstract][Full Text] [Related]
5. [Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia].
Pei RZ; Lu Y; Zhang PS; Liu XH; Chen D; Du XH; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Tang SH
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):213-217. PubMed ID: 32146748
[No Abstract] [Full Text] [Related]
6. Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia.
Gründahl M; Wacker B; Einsele H; Heinz WJ
Mycoses; 2020 Oct; 63(10):1101-1106. PubMed ID: 32738006
[TBL] [Abstract][Full Text] [Related]
7. Antifungal stewardship in solid-organ transplantation: What is needed?
Whitney L; Armstrong-James D; Lyster HS; Reed AK; Dunning J; Nwankwo L; Cheong J
Transpl Infect Dis; 2022 Oct; 24(5):e13894. PubMed ID: 36254506
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
9. Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.
Flett L; Abdelatif R; Baz SA; Brady S; Corbacho B; Common K; Cowling A; Fairhurst C; Fitzmaurice E; Gandhi S; Hilton A; Hope W; Howard A; Laycock J; Lillie P; Mitchell G; Parker A; Peel M; Sheard L; Sneddon J; Taynton T; Tharmanathan P; Torgerson D; Wang HI; Allsup D; Barlow G
Trials; 2024 Jun; 25(1):427. PubMed ID: 38943201
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
[TBL] [Abstract][Full Text] [Related]
11. The increasing problem of treatment-resistant fungal infections: a call for antifungal stewardship programs.
Gupta AK; Venkataraman M; Renaud HJ; Summerbell R; Shear NH; Piguet V
Int J Dermatol; 2021 Dec; 60(12):e474-e479. PubMed ID: 33729567
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal diseases in patients with acute lymphoid leukemia.
Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
[TBL] [Abstract][Full Text] [Related]
13. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.
Lachenmayr SJ; Berking S; Horns H; Strobach D; Ostermann H; Berger K
Mycoses; 2018 Jul; 61(7):464-471. PubMed ID: 29575106
[TBL] [Abstract][Full Text] [Related]
14. Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant.
O'Keeffe JC; Singh N; Slavin MA
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14197. PubMed ID: 37988269
[TBL] [Abstract][Full Text] [Related]
15. Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
Doan TN; Kirkpatrick CM; Walker P; Slavin MA; Ananda-Rajah MR; Morrissey CO; Urbancic KF; Grigg A; Spencer A; Szer J; Seymour JF; Kong DC
J Antimicrob Chemother; 2016 Feb; 71(2):497-505. PubMed ID: 26518050
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia.
Miranti E; Ho DY; Enriquez K; Subramanian AK; Medeiros BC; Epstein DJ
Leuk Lymphoma; 2022 Sep; 63(9):2206-2212. PubMed ID: 35410569
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the impact of antifungal stewardship interventions in the United States.
Hart E; Nguyen M; Allen M; Clark CM; Jacobs DM
Ann Clin Microbiol Antimicrob; 2019 Aug; 18(1):24. PubMed ID: 31434563
[TBL] [Abstract][Full Text] [Related]
18. Improving quality of antifungal use through antifungal stewardship interventions.
Lachenmayr SJ; Strobach D; Berking S; Horns H; Berger K; Ostermann H
Infection; 2019 Aug; 47(4):603-610. PubMed ID: 30805898
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.
Girmenia C; Busca A; Candoni A; Cesaro S; Luppi M; Nosari AM; Pagano L; Rossi G; Venditti A; Aversa F
Med Mycol; 2019 Apr; 57(Supplement_2):S127-S137. PubMed ID: 30816979
[TBL] [Abstract][Full Text] [Related]
20. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
